China Prophylactic Human Vaccine Market Research Report Forecast 2017-2021

April 2017 | 102 pages | ID: CFC8E662314EN
S&P Consulting

Abstracts

The China Prophylactic Human Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Prophylactic Human Vaccine industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Prophylactic Human Vaccine market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Bavarian Nordic A/S
BiondVax Pharmaceuticals Ltd
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer

China Prophylactic Human Vaccine Market: Product Segment Analysis
Type 1
Type 2
Type 3

China Prophylactic Human Vaccine Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 PROPHYLACTIC HUMAN VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Prophylactic Human Vaccine
1.2 Prophylactic Human Vaccine Market Segmentation by Type
  1.2.1 China Production Market Share of Prophylactic Human Vaccine by Type 1n 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Prophylactic Human Vaccine Market Segmentation by Application
  1.3.1 Prophylactic Human Vaccine Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Prophylactic Human Vaccine (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON PROPHYLACTIC HUMAN VACCINE INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Prophylactic Human Vaccine Industry

CHAPTER 3 CHINA PROPHYLACTIC HUMAN VACCINE MARKET COMPETITION BY MANUFACTURERS

3.1 China Prophylactic Human Vaccine Production and Share by Manufacturers (2015 and 2016)
3.2 China Prophylactic Human Vaccine Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Prophylactic Human Vaccine Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Prophylactic Human Vaccine Manufacturing Base Distribution, Production Area and Product Type
3.5 Prophylactic Human Vaccine Market Competitive Situation and Trends
  3.5.1 Prophylactic Human Vaccine Market Concentration Rate
  3.5.2 Prophylactic Human Vaccine Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA PROPHYLACTIC HUMAN VACCINE CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Prophylactic Human Vaccine Capacity, Production and Growth (2012-2017)
4.2 China Prophylactic Human Vaccine Revenue and Growth (2012-2017)
4.3 China Prophylactic Human Vaccine Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA PROPHYLACTIC HUMAN VACCINE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Prophylactic Human Vaccine Production and Market Share by Type (2012-2017)
5.2 China Prophylactic Human Vaccine Revenue and Market Share by Type (2012-2017)
5.3 China Prophylactic Human Vaccine Price by Type (2012-2017)
5.4 China Prophylactic Human Vaccine Production Growth by Type (2012-2017)

CHAPTER 6 CHINA PROPHYLACTIC HUMAN VACCINE MARKET ANALYSIS BY APPLICATION

6.1 China Prophylactic Human Vaccine Consumption and Market Share by Application (2012-2017)
6.2 China Prophylactic Human Vaccine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA PROPHYLACTIC HUMAN VACCINE MANUFACTURERS ANALYSIS

7.1 Bavarian Nordic A/S
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 BiondVax Pharmaceuticals Ltd
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Bharat Biotech International Limited
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 GlaxoSmithKline
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Hualan Biological Engineering
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Janssen Pharmaceuticals
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 MedImmune
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Merck
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Pfizer
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 PROPHYLACTIC HUMAN VACCINE MANUFACTURING COST ANALYSIS

8.1 Prophylactic Human Vaccine Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Prophylactic Human Vaccine

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Prophylactic Human Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA PROPHYLACTIC HUMAN VACCINE MARKET FORECAST (2017-2021)

12.1 China Prophylactic Human Vaccine Production, Revenue Forecast (2017-2021)
12.2 China Prophylactic Human Vaccine Production, Consumption Forecast by Regions (2017-2021)
12.3 China Prophylactic Human Vaccine Production Forecast by Type (2017-2021)
12.4 China Prophylactic Human Vaccine Consumption Forecast by Application (2017-2021)
12.5 Prophylactic Human Vaccine Price Forecast (2017-2021)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prophylactic Human Vaccine
Figure China Production Market Share of Prophylactic Human Vaccine by Type 1n 2016
Table Prophylactic Human Vaccine Consumption Market Share by Application in 2016
Figure China Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2021)
Table China Prophylactic Human Vaccine Capacity of Key Manufacturers (2015 and 2016)
Table China Prophylactic Human Vaccine Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Prophylactic Human Vaccine Capacity of Key Manufacturers in 2015
Figure China Prophylactic Human Vaccine Capacity of Key Manufacturers in 2016
Table China Prophylactic Human Vaccine Production of Key Manufacturers (2015 and 2016)
Table China Prophylactic Human Vaccine Production Share by Manufacturers (2015 and 2016)
Figure 2015 Prophylactic Human Vaccine Production Share by Manufacturers
Figure 2016 Prophylactic Human Vaccine Production Share by Manufacturers
Table China Prophylactic Human Vaccine Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Prophylactic Human Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Prophylactic Human Vaccine Revenue Share by Manufacturers
Table 2016 China Prophylactic Human Vaccine Revenue Share by Manufacturers
Table China Market Prophylactic Human Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Prophylactic Human Vaccine Average Price of Key Manufacturers in 2015
Table Manufacturers Prophylactic Human Vaccine Manufacturing Base Distribution and Sales Area
Table Manufacturers Prophylactic Human Vaccine Product Type
Figure Prophylactic Human Vaccine Market Share of Top 3 Manufacturers
Figure Prophylactic Human Vaccine Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Prophylactic Human Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Prophylactic Human Vaccine Market Share (2012-2017)
Table Bavarian Nordic A/S Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bavarian Nordic A/S Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Bavarian Nordic A/S Prophylactic Human Vaccine Market Share (2012-2017)
Table BiondVax Pharmaceuticals Ltd Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Market Share (2012-2017)
Table Bharat Biotech International Limited Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bharat Biotech International Limited Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Bharat Biotech International Limited Prophylactic Human Vaccine Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Prophylactic Human Vaccine Market Share (2012-2017)
Table Hualan Biological Engineering Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hualan Biological Engineering Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Hualan Biological Engineering Prophylactic Human Vaccine Market Share (2012-2017)
Table Janssen Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Pharmaceuticals Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceuticals Prophylactic Human Vaccine Market Share (2012-2017)
Table MedImmune Basic Information, Manufacturing Base, Production Area and Its Competitors
Table MedImmune Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune Prophylactic Human Vaccine Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Prophylactic Human Vaccine Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Prophylactic Human Vaccine Market Share (2012-2017)
Figure Production Revenue Share of Prophylactic Human Vaccine by Type (2012-2017)
Figure 2015 Revenue Market Share of Prophylactic Human Vaccine by Type
Table China Prophylactic Human Vaccine Price by Type (2012-2017)
Figure China Prophylactic Human Vaccine Production Growth by Type (2012-2017)
Table China Prophylactic Human Vaccine Consumption by Application (2012-2017)
Table China Prophylactic Human Vaccine Consumption Market Share by Application (2012-2017)
Figure China Prophylactic Human Vaccine Consumption Market Share by Application in 2015
Table China Prophylactic Human Vaccine Consumption Growth Rate by Application (2012-2017)
Figure China Prophylactic Human Vaccine Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Human Vaccine
Figure Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure Prophylactic Human Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
Table Major Buyers of Prophylactic Human Vaccine
Table Distributors/Traders List
Figure China Prophylactic Human Vaccine Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Prophylactic Human Vaccine Revenue and Growth Rate Forecast (2017-2021)
Table China Prophylactic Human Vaccine Production, Import, Export and Consumption Forecast (2017-2021)
Table China Prophylactic Human Vaccine Production Forecast by Type (2017-2021)
Table China Prophylactic Human Vaccine Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bavarian Nordic A/S
BiondVax Pharmaceuticals Ltd
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer
Sanofi Pasteur SA
Serum Institute of India Pvt
Shanghai BravoBio